These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

3743 related items for PubMed ID: 6981184

  • 1. Induction of a lymphotoxin-like mediator in peripheral blood and synovial fluid lymphocytes by incubation with synovial fluid from patients with rheumatoid arthritis.
    Burmester GR, Beck P, Eife R, Peter HH, Kalden JR.
    Rheumatol Int; 1981; 1(3):139-43. PubMed ID: 6981184
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Spontaneous cytotoxicity (SCMC) of normal human lymphocytes against a human melanoma cell line: a phenomenon due to a lymphotoxin-like mediator.
    Peter HH, Eife RF, Kalden JR.
    J Immunol; 1976 Feb; 116(2):342-8. PubMed ID: 1082453
    [Abstract] [Full Text] [Related]

  • 4. Integrins and other adhesion molecules on lymphocytes from synovial fluid and peripheral blood of rheumatoid arthritis patients.
    Takahashi H, Söderström K, Nilsson E, Kiessling R, Patarroyo M.
    Eur J Immunol; 1992 Nov; 22(11):2879-85. PubMed ID: 1385154
    [Abstract] [Full Text] [Related]

  • 5. Synovial fluid lymphocytes differ from peripheral blood lymphocytes in patients with rheumatoid arthritis.
    Fox RI, Fong S, Sabharwal N, Carstens SA, Kung PC, Vaughan JH.
    J Immunol; 1982 Jan; 128(1):351-4. PubMed ID: 6976376
    [Abstract] [Full Text] [Related]

  • 6. Characterization of synovial T lymphocytes in rheumatoid arthritis. I. Production of IL-2 dependent T cell clones from synovial fluid and peripheral blood.
    Ofosu-Appiah WA, McKenna RM, Warrington RJ, Wilkins JA.
    Clin Exp Immunol; 1986 Jun; 64(3):555-62. PubMed ID: 3491696
    [Abstract] [Full Text] [Related]

  • 7. Interferon production from peripheral blood, synovial fluid, and synovial tissue lymphocytes in patients with rheumatoid arthritis and ankylosing spondylitis.
    Chou CT, Lee W, Chang ML, Lee CF, Kuo SY, Lin YM.
    J Formos Med Assoc; 1990 Oct; 89(10):845-9. PubMed ID: 1706407
    [Abstract] [Full Text] [Related]

  • 8. Quantitative absorption of interleukin-2 by peripheral blood and synovial fluid lymphocytes from patients with rheumatoid arthritis.
    Knobloch C, Schlesier M, Dräger R, Gärtner M, Peter HH.
    Rheumatol Int; 1985 Oct; 5(3):133-9. PubMed ID: 3925539
    [Abstract] [Full Text] [Related]

  • 9. The influence of synovial fluid from patients with rheumatoid arthritis on the proliferation of peripheral blood lymphocytes and the prostanoid release from monocytes.
    Seitz M, Deimann W, Gemsa D.
    Agents Actions; 1981 Dec; 11(6-7):606-8. PubMed ID: 7340450
    [Abstract] [Full Text] [Related]

  • 10. Studies of rheumatoid synovial fluid lymphocytes. II. A comparison of their behavior with blood mononuclear cells in the autologous mixed lymphocyte reaction and response to TCGF.
    Silver RM, Redelman D, Zvaifler NJ.
    Clin Immunol Immunopathol; 1983 Apr; 27(1):15-27. PubMed ID: 6223751
    [Abstract] [Full Text] [Related]

  • 11. Autocytotoxic cells in rheumatoid synovial fluids.
    Sugiyama E, Suzuki H, Yano S.
    J Rheumatol; 1989 Mar; 16(3):276-9. PubMed ID: 2524590
    [Abstract] [Full Text] [Related]

  • 12. Soluble Fas ligand in the joints of patients with rheumatoid arthritis and osteoarthritis.
    Hashimoto H, Tanaka M, Suda T, Tomita T, Hayashida K, Takeuchi E, Kaneko M, Takano H, Nagata S, Ochi T.
    Arthritis Rheum; 1998 Apr; 41(4):657-62. PubMed ID: 9550474
    [Abstract] [Full Text] [Related]

  • 13. Characterization of IL-2 responsive synovial T lymphocytes in rheumatoid arthritis. II. Functional properties.
    Ofosu-Appiah WA, Warrington RJ, Wilkins JA.
    Rheumatol Int; 1987 Apr; 7(4):147-51. PubMed ID: 3499651
    [Abstract] [Full Text] [Related]

  • 14. Effect of drug therapy on circulating and synovial fluid Ig-secreting cells in rheumatoid arthritis.
    Al-Balaghi S, Ström H, Möller E.
    Ann Rheum Dis; 1985 Apr; 44(4):232-8. PubMed ID: 3885876
    [Abstract] [Full Text] [Related]

  • 15. Enhanced cytotoxicity in the rheumatoid joint.
    LaCour EG, Grayson MH, Ware CF, Pope RM.
    Clin Immunol Immunopathol; 1990 Mar; 54(3):431-41. PubMed ID: 2302843
    [Abstract] [Full Text] [Related]

  • 16. Characterisation of blood and synovial fluid lymphocytes from patients with rheumatoid arthritis and other joint diseases by monoclonal antibodies (OKT series) and acid alpha-naphthyl esterase staining.
    Duclos M, Zeidler H, Liman W, Pichler WJ, Rieber P, Peter HH.
    Rheumatol Int; 1982 Mar; 2(2):75-82. PubMed ID: 6217535
    [Abstract] [Full Text] [Related]

  • 17. Rheumatoid arthritis synovial fluid enhances T cell effector functions.
    Ridderstad A, Abedi-Valugerdi M, Ström H, Möller E.
    J Autoimmun; 1992 Jun; 5(3):333-50. PubMed ID: 1388638
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-2 secretion by synovial fluid lymphocytes in rheumatoid arthritis.
    Ruschen S, Lemm G, Warnatz H.
    Br J Rheumatol; 1988 Oct; 27(5):350-6. PubMed ID: 3263162
    [Abstract] [Full Text] [Related]

  • 19. Immunotherapy in rheumatoid arthritis by T-suppressor lymphocytes: experimental model in vitro.
    Sultan AJ, Jawad AS, Berry H, Sharp J.
    Clin Rheumatol; 1986 Dec; 5(4):450-8. PubMed ID: 2949911
    [Abstract] [Full Text] [Related]

  • 20. Inhibited apoptosis of synovial fluid lymphocytes in children with juvenile idiopathic arthritis is associated with increased expression of myeloid cell leukemia 1 and XIAP proteins.
    Smolewska E, Stanczyk J, Robak T, Smolewski P.
    J Rheumatol; 2006 Aug; 33(8):1684-90. PubMed ID: 16881124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 188.